Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2022-12-23

Insight into molecular recognition between a G- protein-coupled receptor, rhodopsin, and its desensitizing kinase, GRK-1.

Objetivo

G protein coupled receptors (GPCRs) are membrane proteins, which mediate a number of physiological signal transduction processes. Currently, about 60% of known pharmacological targets belong to the GPCR superfamily. Rhodopsin is a member of this super family of receptors, which initiates visual transduction. This signalling process comprises biochemical pathways underlying the complex sensorial phenomenon of vision. Activation of rhodopsin by light is caused by the cis-trans summarisation of its 11-cis-retinal chromophore upon light absorption. This initial ultra fast chemical event promotes a conformational change in rhodopsin, which allows it to bind and to activate a G protein called Gt, or transducin. Activation of Gt, in turn, is followed by a cascade of enzymatic reactions resulting in hyperpolarization of photoreceptor cell membranes. Much attention has been devoted to this activation mechanism, while the inactivation mechanism of photoactivated rhodopsin by phosphorylation by its kinase, GRK-1, is still less understood. In particular, the structural determinants in the cytoplasmic domain of rhodopsin responsible for GRK-1 binding and activation are still not determined in detail; the same is true for the domains and specific amino acid residues of GRK-1 responsible for interaction with and phosphorylation of rhodopsin. Furthermore, kinetic information about the receptor-kinase enzymatic reaction is still lacking. This knowledge is crucial for understanding the rhodopsin inactivation process and the role of the receptor-kinase interactions (as well as other involved key players like Ca2+) in retinal degenerations, particularly Retinitis Pigmentosa. Rhodopsin phosphorylation by its kinase GRK-1 is also a critical step in the desensitization process and plays a role in the fine regulation of the physiological process of light adaptation.

In the present project, key amino acid residues and structural elements in the cytoplasmic regions of rhodopsin (including membrane boundaries) crucial for rhodopsin phosphorylation by and interaction with GRK-1 will be elucidated. To this aim, rhodopsin mutants, including those related to the retinal degenerative disease Retinitis Pigmentosa, in these domains would be produced. The rhodopsin mutants will be structurally and biochemically characterized, and the levels of their phosphorylation by GRK-1 will be compared to reveal amino acid residues in rhodopsin crucial for its recognition by GRK-1. The phenomenon of constitutive phosphorylation of rhodopsin will also be investigated. This will be followed by a detailed study of the different kinetic parameters, with the aim to obtain a complete mechanistic description of the receptor-kinase interaction (both binding and dissociation), will be undertaken. This will be done using a novel spectroscopic technique, surface plasmon resonance spectroscopy (SPR-spectroscopy). In these experiments, both non-phosphorylated and phosphorylated rhodopsin of a wild type.

Programa(s)

Programas de financiación plurianuales que definen las prioridades de la UE en materia de investigación e innovación.

Tema(s)

Las convocatorias de propuestas se dividen en temas. Un tema define una materia o área específica para la que los solicitantes pueden presentar propuestas. La descripción de un tema comprende su alcance específico y la repercusión prevista del proyecto financiado.

Convocatoria de propuestas

Procedimiento para invitar a los solicitantes a presentar propuestas de proyectos con el objetivo de obtener financiación de la UE.

Datos no disponibles

Régimen de financiación

Régimen de financiación (o «Tipo de acción») dentro de un programa con características comunes. Especifica: el alcance de lo que se financia; el porcentaje de reembolso; los criterios específicos de evaluación para optar a la financiación; y el uso de formas simplificadas de costes como los importes a tanto alzado.

Datos no disponibles

Coordinador

Universitat Autònoma de Barcelona, Fac. Medicina
Aportación de la UE
Sin datos
Dirección
Campus Bellaterra
08193 Bellaterra (Barcelona)
España

Ver en el mapa

Coste total

Los costes totales en que ha incurrido esta organización para participar en el proyecto, incluidos los costes directos e indirectos. Este importe es un subconjunto del presupuesto total del proyecto.

Sin datos

Participantes (4)

Mi folleto 0 0